How are you aware if a “optimistic” research is optimistic? And what if medical trial individuals unionized?
We talk about all that and extra on the most recent episode of “The Readout LOUD,” STAT’s biotech podcast. First, we dig into Biogen’s (BIIB) much-dissected knowledge on a remedy for Alzheimer’s illness, with on-the-ground takes from consultants at a scientific convention. Then, STAT’s Eric Boodman joins us to spin a drug-discovery yarn involving one-eyed sheep, Basque farmers, and the search to deal with a uncommon type of most cancers.
For extra on what we cowl, right here’s the Biogen information, and right here’s the story on the hunt for a brand new medication.
And if in case you have any suggestions for us — matters to cowl, company to ask, vocal tics to stop — you’ll be able to e-mail email@example.com.
Involved in sponsoring a future episode of “The Readout LOUD”? Electronic mail us at firstname.lastname@example.org.